S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trial

S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trial

Bibliographic Details
Main Authors: Kim, Seung Tae, Hong, Yong Sang, Lim, Ho Yeong, Lee, Jeeyun, Kim, Tae Won, Kim, Kyu-Pyo, Kim, Sun Young, Baek, Ji Yeon, Kim, Jee Hyun, Lee, Keun-Wook, Chung, Ik-Joo, Cho, Sang-Hee, Lee, Kyung Hee, Shin, Sang Joon, Kang, Hye Jin, Shin, Dong Bok, Lee, Jae Won, Jo, Sook Jung, Park, Young Suk
Format: Online
Language:English
Published: BioMed Central 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289339/
Description
Summary:

Similar Items